Peroxisome proliferator-activated receptor-γ regulates the expression and function of very-low-density lipoprotein receptor
- 1 January 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 298 (1), E68-E79
- https://doi.org/10.1152/ajpendo.00367.2009
Abstract
Very-low-density lipoprotein receptor (VLDLR) is a member of the low-density receptor family, highly expressed in adipose tissue, heart, and skeletal muscle. It binds apolipoprotein E-triglyceride-rich lipoproteins and plays a significant role in triglyceride metabolism. PPARγ is a primary regulator of lipid metabolism in adipocytes and controls the expression of an array of genes involved in lipid trafficking in adipocytes. However, it is not known whether VLDLR is also under the control of PPARγ. In this study, we investigated the role of PPARγ in the regulation of VLDLR expression and function in vivo and in vitro. During the differentiation of 3T3-L1 preadipocytes, the levels of VLDLR protein and mRNA increased in parallel with the induction of PPARγ expression and reached maximum in mature adipocytes. Treatment of differentiated adipocytes with PPARγ agonist pioglitazone upregulated VLDLR expression in dose- and time-dependent manners. In contrast, specific inhibition of PPARγ significantly downregulated the protein level of VLDLR. Induction of VLDLR is also demonstrated in vivo in adipose tissue of wild-type (WT) mice treated with pioglitazone. In addition, pioglitazone increased plasma triglyceride-rich lipoprotein clearance and increased epididymal fat mass in WT mice but failed to induce similar effects in vldlr−/−mice. These results were further corroborated by the finding that pioglitazone treatment enhanced adipogenesis and lipid deposition in preadipocytes of WT mice, while its effect in VLDLR-null preadipocytes was significantly blunted. These findings provide direct evidence that VLDLR expression is regulated by PPARγ and contributes in lipid uptake and adipogenesis.Keywords
This publication has 50 references indexed in Scilit:
- Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein LipaseArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- GPIHBP1 and lipolysis: an updateCurrent Opinion in Lipidology, 2009
- The Expression of GPIHBP1, an Endothelial Cell Binding Site for Lipoprotein Lipase and Chylomicrons, Is Induced by Peroxisome Proliferator-Activated Receptor-γMolecular Endocrinology, 2008
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in miceJCI Insight, 2007
- Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizingJCI Insight, 2007
- Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null miceJCI Insight, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial HypertrophyPublished by Elsevier BV ,2001
- Total parenteral nutrition stimulates hepatic cholesterol synthesis in the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995